Annals of Oncology

in this issue:

in this issue
Ann Oncol 18: 405; doi:10.1093/annonc/mdm067
[Extract] [Full Text] [PDF] [Request Permissions]

editorial:

N van Zandwijk and MJ van de Vijver

clairvoyance or reliable prediction of the future?
Ann Oncol 18: 407-408; doi:10.1093/annonc/mdl503
[Extract] [Full Text] [PDF] [Request Permissions]

reviews:

CE Humber, JF Tierney, RP Symonds, M Collingwood, J Kirwan, C Williams, and JA Green

Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration
Annals of Oncology Advance Access published on December 5, 2006
Ann Oncol 18: 409-420; doi:10.1093/annonc/mdl417
[Abstract] [Full Text] [PDF] [Request Permissions]

JJ Cruz, A Ocaña, E Del Barco, and A Pandiella

Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer
Annals of Oncology Advance Access published on July 27, 2006
Ann Oncol 18: 421-430; doi:10.1093/annonc/mdl175
[Abstract] [Full Text] [PDF] [Request Permissions]

C Bosetti, P Boffetta, and C La Vecchia

Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005
Annals of Oncology Advance Access published on August 25, 2006
Ann Oncol 18: 431-446; doi:10.1093/annonc/mdl172
[Abstract] [Full Text] [PDF] [Request Permissions]

original articles:

lung cancer:

R Dziadziuszko, B Holm, BG Skov, K Osterlind, MV Sellers, WA Franklin, PA Bunn, Jr, M Varella-Garcia, and FR Hirsch

Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy
Annals of Oncology Advance Access published on November 2, 2006
Ann Oncol 18: 447-452; doi:10.1093/annonc/mdl407
[Abstract] [Full Text] [PDF] [Request Permissions]

GJ Weiss, R Rosell, F Fossella, M Perry, R Stahel, F Barata, B Nguyen, S Paul, P McAndrews, N Hanna, K Kelly, and PA Bunn, Jr

The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer
Ann Oncol 18: 453-460; doi:10.1093/annonc/mdl454
[Abstract] [Full Text] [PDF] [Request Permissions]

P Bidoli, N Zilembo, D Cortinovis, L Mariani, L Isa, E Aitini, D Cullurà, F Pari, P Nova, M Mancin, B Formisano, and E Bajetta

Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study
Annals of Oncology Advance Access published on November 16, 2006
Ann Oncol 18: 461-467; doi:10.1093/annonc/mdl415
[Abstract] [Full Text] [PDF] [Request Permissions]

breast cancer:

O Gentilini, E Botteri, N Rotmensz, B Santillo, N Peradze, RC Saihum, M Intra, A Luini, V Galimberti, A Goldhirsch, and U Veronesi

When can a second conservative approach be considered for ipsilateral breast tumour recurrence?
Annals of Oncology Advance Access published on December 8, 2006
Ann Oncol 18: 468-472; doi:10.1093/annonc/mdl424
[Abstract] [Full Text] [PDF] [Request Permissions]

U Veronesi, C De Cicco, VE Galimberti, JR Fernandez, N Rotmensz, G Viale, G Spano, A Luini, M Intra, P Veronesi, A Berrettini, and G Paganelli

A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases
Annals of Oncology Advance Access published on December 12, 2006
Ann Oncol 18: 473-478; doi:10.1093/annonc/mdl425
[Abstract] [Full Text] [PDF] [Request Permissions]

G Oskay-Özcelik, W Lehmacher, D Könsgen, H Christ, M Kaufmann, W Lichtenegger, M Bamberg, D Wallwiener, F Overkamp, K Diedrich, G von Minckwitz, K Höffken, S Seeber, R Mirz, and J Sehouli

Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients
Annals of Oncology Advance Access published on February 1, 2007
Ann Oncol 18: 479-484; doi:10.1093/annonc/mdl456
[Abstract] [Full Text] [PDF] [Request Permissions]

gynecologic tumors:

SM Alam, J Fujimoto, I Jahan, E Sato, and T Tamaya

Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers
Annals of Oncology Advance Access published on November 15, 2006
Ann Oncol 18: 485-490; doi:10.1093/annonc/mdl414
[Abstract] [Full Text] [PDF] [Request Permissions]

JMA Pijnenborg, GC Dam-de Veen, N Kisters, B Delvoux, M van Engeland, JG Herman, and PG Groothuis

RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer
Annals of Oncology Advance Access published on December 14, 2006
Ann Oncol 18: 491-497; doi:10.1093/annonc/mdl455
[Abstract] [Full Text] [PDF] [Request Permissions]

gastrointestinal tumors:

J Taïeb, T Lecomte, T Aparicio, A Asnacios, T Mansourbakht, P Artru, D Fallik, JP Spano, B Landi, G Lledo, and J Desrame

FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Entérologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study
Annals of Oncology Advance Access published on December 8, 2006
Ann Oncol 18: 498-503; doi:10.1093/annonc/mdl427
[Abstract] [Full Text] [PDF] [Request Permissions]

H-C Kwon, MS Roh, SY Oh, S-H Kim, MC Kim, J-S Kim, and H-J Kim

Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer
Ann Oncol 18: 504-509; doi:10.1093/annonc/mdl430
[Abstract] [Full Text] [PDF] [Request Permissions]

C Pinto, F Di Fabio, S Siena, S Cascinu, FL Rojas Llimpe, C Ceccarelli, V Mutri, L Giannetta, S Giaquinta, C Funaioli, R Berardi, C Longobardi, E Piana, and AA Martoni

Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)
Annals of Oncology Advance Access published on December 12, 2006
Ann Oncol 18: 510-517; doi:10.1093/annonc/mdl459
[Abstract] [Full Text] [PDF] [Request Permissions]

urogenital tumors:

K Fizazi, L Morat, L Chauveinc, D Prapotnich, R De Crevoisier, B Escudier, X Cathelineau, F Rozet, G Vallancien, L Sabatier, and JC Soria

High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity
Ann Oncol 18: 518-521; doi:10.1093/annonc/mdl419
[Abstract] [Full Text] [PDF] [Request Permissions]

J Bellmunt, L Paz-Ares, M Cuello, FL Cecere, S Albiol, V Guillem, E Gallardo, J Carles, P Mendez, JJ de la Cruz, M Taron, R Rosell, and J Baselga On behalf of Spanish Oncology Genitourinary Group (SOGUG)

Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
Annals of Oncology Advance Access published on January 17, 2007
Ann Oncol 18: 522-528; doi:10.1093/annonc/mdl435
[Abstract] [Full Text] [PDF] [Request Permissions]

hematologic malignancies:

Y-B Yu, J-P Gau, J-Y You, H-H Chern, W-K Chau, C-H Tzeng, C-H Ho, and H-C Hsu

Cost-effectiveness of postremission intensive therapy in patients with acute leukemia
Annals of Oncology Advance Access published on December 12, 2006
Ann Oncol 18: 529-534; doi:10.1093/annonc/mdl420
[Abstract] [Full Text] [PDF] [Request Permissions]

KW Song, MJ Barnett, RD Gascoyne, M Chhanabhai, DL Forrest, DE Hogge, JC Lavoie, SH Nantel, TJ Nevill, JD Shepherd, CA Smith, HJ Sutherland, CL Toze, NJ Voss, and JM Connors

Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes
Annals of Oncology Advance Access published on December 8, 2006
Ann Oncol 18: 535-540; doi:10.1093/annonc/mdl426
[Abstract] [Full Text] [PDF] [Request Permissions]

H-T Arkenau, G Chong, D Cunningham, D Watkins, R Agarwal, B Sirohi, M Trumper, A Norman, A Wotherspoon, and A Horwich

The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma
Annals of Oncology Advance Access published on December 12, 2006
Ann Oncol 18: 541-545; doi:10.1093/annonc/mdl434
[Abstract] [Full Text] [PDF] [Request Permissions]

supportive care:

HT Mouridsen, SW Langer, J Buter, H Eidtmann, G Rosti, M de Wit, P Knoblauch, A Rasmussen, K Dahlstrøm, PB Jensen, and G Giaccone

Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies
Annals of Oncology Advance Access published on December 21, 2006
Ann Oncol 18: 546-550; doi:10.1093/annonc/mdl413
[Abstract] [Full Text] [PDF] [Request Permissions]

D Fagnani, R Franchi, C Porta, P Pugliese, K Borgonovo, A Bertolini, M Duro, A Ardizzoia, V Filipazzi, L Isa, C Vergani, M Milani, and C Cimminiello On behalf of POLONORD Group

Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis
Annals of Oncology Advance Access published on December 8, 2006
Ann Oncol 18: 551-555; doi:10.1093/annonc/mdl431
[Abstract] [Full Text] [PDF] [Request Permissions]

D Aguiar Bujanda, U Bohn Sarmiento, MÁ Cabrera Suárez, and J Aguiar Morales

Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis
Annals of Oncology Advance Access published on November 2, 2006
Ann Oncol 18: 556-560; doi:10.1093/annonc/mdl408
[Abstract] [Full Text] [PDF] [Request Permissions]

phase I and pharmacokinetics:

C Sessa, S Cresta, T Cerny, J Baselga, E Rota Caremoli, A Malossi, D Hess, J Trigo, M Zucchetti, M D'Incalci, A Zaniboni, G Capri, B Gatti, P Carminati, C Zanna, S Marsoni, and L Gianni

Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors
Annals of Oncology Advance Access published on December 5, 2006
Ann Oncol 18: 561-568; doi:10.1093/annonc/mdl418
[Abstract] [Full Text] [PDF] [Request Permissions]

L Scott, O Soepenberg, J Verweij, MJA de Jonge, AS Th Planting, D McGovern, P Principe, R Obach, and C Twelves

A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours
Ann Oncol 18: 569-575; doi:10.1093/annonc/mdl439
[Abstract] [Full Text] [PDF] [Request Permissions]

D Santini, V Virzí, B Vincenzi, L Rocci, V Leoni, and G Tonini

A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients
Annals of Oncology Advance Access published on December 8, 2006
Ann Oncol 18: 576-580; doi:10.1093/annonc/mdl440
[Abstract] [Full Text] [PDF] [Request Permissions]

epidemiology:

J Ferlay, P Autier, M Boniol, M Heanue, M Colombet, and P Boyle

Estimates of the cancer incidence and mortality in Europe in 2006
Annals of Oncology Advance Access published on February 7, 2007
Ann Oncol 18: 581-592; doi:10.1093/annonc/mdl498
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

F Levi, F Lucchini, E Negri, and C La Vecchia

Continuing declines in cancer mortality in the European Union
Annals of Oncology Advance Access published on December 12, 2006
Ann Oncol 18: 593-595; doi:10.1093/annonc/mdl437
[Abstract] [Full Text] [PDF] [Request Permissions]

A Zucchetto, L Dal Maso, A Tavani, M Montella, V Ramazzotti, R Talamini, V Canzonieri, A Garbeglio, E Negri, S Franceschi, and C La Vecchia

History of treated hypertension and diabetes mellitus and risk of renal cell cancer
Annals of Oncology Advance Access published on December 8, 2006
Ann Oncol 18: 596-600; doi:10.1093/annonc/mdl438
[Abstract] [Full Text] [PDF] [Request Permissions]

letters to the editor:

P Bossi, C Liberatoscioli, C Bergamini, LD Locati, S Fava, G Rinaldi, E Orlandi, P Olmi, E Tagliabue, S Ménard, and L Licitra

Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients
Annals of Oncology Advance Access published on October 30, 2006
Ann Oncol 18: 601-602; doi:10.1093/annonc/mdl409
[Extract] [Full Text] [PDF] [Request Permissions]

M Morales, M Trujillo, M del Carmen Maeso, and M-A Piris

Thymoma and progressive T-cell lymphocytosis
Annals of Oncology Advance Access published on October 30, 2006
Ann Oncol 18: 603-604; doi:10.1093/annonc/mdl406
[Extract] [Full Text] [PDF] [Request Permissions]

T Cai, G Conti, M Lorenzini, and R Bartoletti

Artificial intelligences in urological practice: the key to success?
Annals of Oncology Advance Access published on December 8, 2006
Ann Oncol 18: 604-605; doi:10.1093/annonc/mdl411
[Extract] [Full Text] [PDF] [Request Permissions]

G Nicolle, E Comperat, N Nicolaïew, G Cancel-Tassin, and O Cussenot

Metastin (KISS-1) and metastin-coupled receptor (GPR54) expression in transitional cell carcinoma of the bladder
Annals of Oncology Advance Access published on December 12, 2006
Ann Oncol 18: 605-607; doi:10.1093/annonc/mdl421
[Extract] [Full Text] [PDF] [Request Permissions]

D Bernardi, D Errante, A Bianco, and L Salvagno

Are sales representatives and the sale strategies of pharmaceutical companies getting too aggressive towards physicians?
Annals of Oncology Advance Access published on December 12, 2006
Ann Oncol 18: 607; doi:10.1093/annonc/mdl422
[Extract] [Full Text] [PDF] [Request Permissions]

TM Bosch, I Meijerman, JH Beijnen, SW van Thiel, and LT Vlasveld

Lethal toxicity of uracil/tegafur in the treatment of sigmoid carcinoma
Annals of Oncology Advance Access published on December 14, 2006
Ann Oncol 18: 607-608; doi:10.1093/annonc/mdl432
[Extract] [Full Text] [PDF] [Request Permissions]

S Vieillot, D Pouessel, NM de Champfleur, C Becht, and S Culine

Reversible posterior leukoencephalopathy syndrome after carboplatin therapy
Annals of Oncology Advance Access published on December 11, 2006
Ann Oncol 18: 608-609; doi:10.1093/annonc/mdl436
[Extract] [Full Text] [PDF] [Request Permissions]

G Meyer

Does low-molecular-weight heparin influence cancer-related mortality?
Ann Oncol 18: 609-610; doi:10.1093/annonc/mdl487
[Extract] [Full Text] [PDF] [Request Permissions]

erratum:

RA Soo, J Wu, A Aggarwal, Q Tao, W Hsieh, T Putti, KB Tan, WL Soon, YF Lai, B Mow, S Hsu, KS Loh, L Tan, P Tan, and B-C Goh

Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression. Ann Oncol 2006; 17: 1625–1630
Ann Oncol 18: 611; doi:10.1093/annonc/mdm054
[Extract] [Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.